Shanghai Healthcare Capital
Overview
Shanghai Healthcare Capital is a municipal-level life sciences investment fund based in Shanghai, dedicated to supporting innovative companies in biotechnology, medical devices, diagnostics, and healthcare services.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SiBio | Dec 2022 | Series D | Lead |
| Beijing Surgerii Robotics | Dec 2025 | Series D | Co-investor |
| ArriVent | Mar 2023 | Series B | Co-investor |
| Geneos Therapeutics | Sep 2023 | Series A Extension | Lead |
| NanoRibo (Shanghai) Biotechnology Co., Ltd. | Feb 2022 | Early Funding | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Shanghai Healthcare Capital based?
Shanghai Healthcare Capital is headquartered in Shanghai, China.
When was Shanghai Healthcare Capital founded?
Shanghai Healthcare Capital was founded in 2020.
How many portfolio companies does Shanghai Healthcare Capital have?
Shanghai Healthcare Capital has 19 portfolio companies in Caplight's dataset.
What are some companies in Shanghai Healthcare Capital's portfolio?
Portfolio companies visible on Caplight include SiBio, Beijing Surgerii Robotics, ArriVent, Geneos Therapeutics, NanoRibo (Shanghai) Biotechnology Co., Ltd..
What was Shanghai Healthcare Capital's most recent investment shown here?
Shanghai Healthcare Capital's most recent investment in this portfolio sample was in Beijing Surgerii Robotics in 2025.
What sectors does Shanghai Healthcare Capital focus on?
Shanghai Healthcare Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Consumer & Commerce, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Shanghai Healthcare Capital focus on?
Stage focus information for Shanghai Healthcare Capital is not publicly available.
What is Shanghai Healthcare Capital's AUM?
Shanghai Healthcare Capital's assets under management are estimated between $1.4B and $7.0B.